APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Vaccine Adjuvants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Vaccine Adjuvants Industry Growth and Trends Forecast to 2032

28 December 202599 pages

Choose your research edition.

Industry ResearchHuman Vaccine Adjuvants Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Vaccine Adjuvants Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Vaccine Adjuvants Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Vaccine Adjuvants Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Human Vaccine Adjuvants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Vaccine Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Vaccine Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Vaccine Adjuvants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Vaccine Adjuvants include GSK, Zhifei Biological, Escon, Sanofi, Rico Bio, Huanuotai Biological, SEPPIC, CSL Limited and Croda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Vaccine Adjuvants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Vaccine Adjuvants market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Vaccine Adjuvants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Vaccine Adjuvants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Vaccine Adjuvants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Vaccine Adjuvants Market by Company

GSK

Zhifei Biological

Escon

Sanofi

Rico Bio

Huanuotai Biological

SEPPIC

CSL Limited

Croda

Human Vaccine Adjuvants Segment by Type

Aluminium Salt Adjuvant

Oil Emulsion Adjuvant

Others

Human Vaccine Adjuvants Segment by Application

Commercial

Research

Human Vaccine Adjuvants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aluminium Salt Adjuvant Table 2. Major Company of Oil Emulsion Adjuvant Table 3. Major Company of Others Table 4. Global Human Vaccine Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 6. Global Human Vaccine Adjuvants Sales Market Share in Volume by Type (2021-2026) Table 7. Global Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 8. Global Human Vaccine Adjuvants Sales Market Share in Value by Type (2021-2026) Table 9. Global Human Vaccine Adjuvants Price by Type (2021-2026) & (US$/Ton) Table 10. Global Human Vaccine Adjuvants Sales by Type (2027-2032) & (Tons) Table 11. Global Human Vaccine Adjuvants Sales Market Share in Volume by Type (2027-2032) Table 12. Global Human Vaccine Adjuvants Sales by Type (2027-2032) & (US$ Million) Table 13. Global Human Vaccine Adjuvants Sales Market Share in Value by Type (2027-2032) Table 14. Global Human Vaccine Adjuvants Price by Type (2027-2032) & (US$/Ton) Table 15. North America Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 16. North America Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 18. Europe Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 22. Latin America Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Human Vaccine Adjuvants Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Human Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 25. Human Vaccine Adjuvants Industry Trends Table 26. Human Vaccine Adjuvants Industry Drivers Table 27. Human Vaccine Adjuvants Industry Opportunities and Challenges Table 28. Human Vaccine Adjuvants Industry Restraints Table 29. Global Human Vaccine Adjuvants Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Human Vaccine Adjuvants Revenue Market Share by Company (2021-2026) Table 31. Global Human Vaccine Adjuvants Sales by Company (2021-2026) & (Tons) Table 32. Global Human Vaccine Adjuvants Sales Share by Company (2021-2026) Table 33. Global Human Vaccine Adjuvants Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Human Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Human Vaccine Adjuvants Major Company Production Sites and Headquarters Table 36. Global Human Vaccine Adjuvants Company, Product Type & Application Table 37. Global Human Vaccine Adjuvants Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Human Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Human Vaccine Adjuvants Sales by Region (2021-2026) & (Tons) Table 42. Global Human Vaccine Adjuvants Sales Market Share in Volume by Region (2021-2026) Table 43. Global Human Vaccine Adjuvants Sales by Region (2021-2026) & (US$ Million) Table 44. Global Human Vaccine Adjuvants Sales Market Share in Value by Region (2021-2026) Table 45. Global Human Vaccine Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Human Vaccine Adjuvants Sales by Region (2027-2032) & (Tons) Table 47. Global Human Vaccine Adjuvants Sales Market Share in Volume by Region (2027-2032) Table 48. Global Human Vaccine Adjuvants Sales by Region (2027-2032) & (US$ Million) Table 49. Global Human Vaccine Adjuvants Sales Market Share in Value by Region (2027-2032) Table 50. Global Human Vaccine Adjuvants Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Human Vaccine Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 53. Global Human Vaccine Adjuvants Sales Market Share in Volume by Application (2021-2026) Table 54. Global Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 55. Global Human Vaccine Adjuvants Sales Market Share in Value by Application (2021-2026) Table 56. Global Human Vaccine Adjuvants Price by Application (2021-2026) & (US$/Ton) Table 57. Global Human Vaccine Adjuvants Sales by Application (2027-2032) & (Tons) Table 58. Global Human Vaccine Adjuvants Sales Market Share in Volume by Application (2027-2032) Table 59. Global Human Vaccine Adjuvants Sales by Application (2027-2032) & (US$ Million) Table 60. Global Human Vaccine Adjuvants Sales Market Share in Value by Application (2027-2032) Table 61. Global Human Vaccine Adjuvants Price by Application (2027-2032) & (US$/Ton) Table 62. North America Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 63. North America Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 65. Europe Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 69. Latin America Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Human Vaccine Adjuvants Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Human Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. GSK Human Vaccine Adjuvants Product Portfolio Table 76. GSK Recent Development Table 77. Zhifei Biological Company Information Table 78. Zhifei Biological Business Overview Table 79. Zhifei Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Zhifei Biological Human Vaccine Adjuvants Product Portfolio Table 81. Zhifei Biological Recent Development Table 82. Escon Company Information Table 83. Escon Business Overview Table 84. Escon Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Escon Human Vaccine Adjuvants Product Portfolio Table 86. Escon Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Sanofi Human Vaccine Adjuvants Product Portfolio Table 91. Sanofi Recent Development Table 92. Rico Bio Company Information Table 93. Rico Bio Business Overview Table 94. Rico Bio Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Rico Bio Human Vaccine Adjuvants Product Portfolio Table 96. Rico Bio Recent Development Table 97. Huanuotai Biological Company Information Table 98. Huanuotai Biological Business Overview Table 99. Huanuotai Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Huanuotai Biological Human Vaccine Adjuvants Product Portfolio Table 101. Huanuotai Biological Recent Development Table 102. SEPPIC Company Information Table 103. SEPPIC Business Overview Table 104. SEPPIC Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. SEPPIC Human Vaccine Adjuvants Product Portfolio Table 106. SEPPIC Recent Development Table 107. CSL Limited Company Information Table 108. CSL Limited Business Overview Table 109. CSL Limited Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. CSL Limited Human Vaccine Adjuvants Product Portfolio Table 111. CSL Limited Recent Development Table 112. Croda Company Information Table 113. Croda Business Overview Table 114. Croda Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Croda Human Vaccine Adjuvants Product Portfolio Table 116. Croda Recent Development Table 117. North America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 118. North America Human Vaccine Adjuvants Sales by Country (2021-2026) & (Tons) Table 119. North America Human Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 120. North America Human Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 121. North America Human Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 122. North America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Human Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Human Vaccine Adjuvants Market Share by Country (2021-2026) Table 125. North America Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Human Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 127. Europe Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 128. Europe Human Vaccine Adjuvants Sales by Country (2021-2026) & (Tons) Table 129. Europe Human Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 130. Europe Human Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 131. Europe Human Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Human Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Human Vaccine Adjuvants Market Share by Country (2021-2026) Table 135. Europe Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Human Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Human Vaccine Adjuvants Sales by Country (2021-2026) & (Tons) Table 139. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Human Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 141. Asia-Pacific Human Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Human Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Human Vaccine Adjuvants Market Share by Country (2021-2026) Table 145. Asia-Pacific Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Human Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 147. Latin America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Latin America Human Vaccine Adjuvants Sales by Country (2021-2026) & (Tons) Table 149. Latin America Human Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 150. Latin America Human Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 151. Latin America Human Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Human Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Human Vaccine Adjuvants Market Share by Country (2021-2026) Table 155. Latin America Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Human Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Human Vaccine Adjuvants Sales by Country (2021-2026) & (Tons) Table 159. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Human Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (Tons) Table 161. Middle East and Africa Human Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Human Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Human Vaccine Adjuvants Market Share by Country (2021-2026) Table 165. Middle East and Africa Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Human Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Human Vaccine Adjuvants Distributors List Table 170. Human Vaccine Adjuvants Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Human Vaccine Adjuvants Image Figure 2. Global Human Vaccine Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Vaccine Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Vaccine Adjuvants Sales (2021-2032) & (Tons) Figure 5. Aluminium Salt Adjuvant Image Figure 6. Global Aluminium Salt Adjuvant Sales YoY Growth (2021-2032) & (Tons) Figure 7. Oil Emulsion Adjuvant Image Figure 8. Global Oil Emulsion Adjuvant Sales YoY Growth (2021-2032) & (Tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Human Vaccine Adjuvants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Human Vaccine Adjuvants Market Share by Type 2025 VS 2032 Figure 13. North America Human Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 14. North America Human Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 15. Europe Human Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 16. Europe Human Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Human Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Human Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 19. Latin America Human Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Human Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Human Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Human Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Human Vaccine Adjuvants Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Commercial Image Figure 26. Global Commercial Sales YoY Growth (2021-2032) & (Tons) Figure 27. Research Image Figure 28. Global Research Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Human Vaccine Adjuvants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Vaccine Adjuvants Market Share by Application 2025 VS 2032 Figure 31. North America Human Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 32. North America Human Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 33. Europe Human Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 34. Europe Human Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Human Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Human Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 37. Latin America Human Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Human Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Human Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Human Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 41. North America Human Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Human Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Human Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Human Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Human Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Human Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Human Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Human Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Human Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Human Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Human Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Human Vaccine Adjuvants Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Human Vaccine Adjuvants Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Aluminium Salt Adjuvant
  • Oil Emulsion Adjuvant
  • Others
Applications
  • Commercial
  • Research
Companies covered
  • GSK
  • Zhifei Biological
  • Escon
  • Sanofi
  • Rico Bio
  • Huanuotai Biological
  • SEPPIC
  • CSL Limited
  • Croda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Vaccine Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Vaccine Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Vaccine Adjuvants Market by Type
  6. 1.3.1 Aluminium Salt Adjuvant
  7. 1.3.2 Oil Emulsion Adjuvant
  8. 1.3.3 Others
  9. 1.4 Global Human Vaccine Adjuvants Market Size by Type
  10. 1.4.1 Global Human Vaccine Adjuvants Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Human Vaccine Adjuvants Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Human Vaccine Adjuvants Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Human Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Human Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Human Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Human Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Human Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Vaccine Adjuvants Industry Trends
  2. 2.2 Human Vaccine Adjuvants Industry Drivers
  3. 2.3 Human Vaccine Adjuvants Industry Opportunities and Challenges
  4. 2.4 Human Vaccine Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Vaccine Adjuvants Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Vaccine Adjuvants Sales (2021-2026)
  3. 3.3 Global Top Players by Human Vaccine Adjuvants Price (2021-2026)
  4. 3.4 Global Human Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Vaccine Adjuvants Major Company Production Sites & Headquarters
  6. 3.6 Global Human Vaccine Adjuvants Company, Product Type & Application
  7. 3.7 Global Human Vaccine Adjuvants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Vaccine Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Vaccine Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
4 Human Vaccine Adjuvants Regional Status and Outlook
  1. 4.1 Global Human Vaccine Adjuvants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Vaccine Adjuvants Historic Market Size by Region
  3. 4.2.1 Global Human Vaccine Adjuvants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Vaccine Adjuvants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Vaccine Adjuvants Forecasted Market Size by Region
  7. 4.3.1 Global Human Vaccine Adjuvants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Vaccine Adjuvants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Vaccine Adjuvants by Application
  1. 5.1 Human Vaccine Adjuvants Market by Application
  2. 5.1.1 Commercial
  3. 5.1.2 Research
  4. 5.2 Global Human Vaccine Adjuvants Market Size by Application
  5. 5.2.1 Global Human Vaccine Adjuvants Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Vaccine Adjuvants Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Vaccine Adjuvants Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Human Vaccine Adjuvants Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Zhifei Biological
  8. 6.2.1 Zhifei Biological Company Information
  9. 6.2.2 Zhifei Biological Business Overview
  10. 6.2.3 Zhifei Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhifei Biological Human Vaccine Adjuvants Product Portfolio
  12. 6.2.5 Zhifei Biological Recent Developments
  13. 6.3 Escon
  14. 6.3.1 Escon Company Information
  15. 6.3.2 Escon Business Overview
  16. 6.3.3 Escon Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Escon Human Vaccine Adjuvants Product Portfolio
  18. 6.3.5 Escon Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Human Vaccine Adjuvants Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Rico Bio
  26. 6.5.1 Rico Bio Company Information
  27. 6.5.2 Rico Bio Business Overview
  28. 6.5.3 Rico Bio Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Rico Bio Human Vaccine Adjuvants Product Portfolio
  30. 6.5.5 Rico Bio Recent Developments
  31. 6.6 Huanuotai Biological
  32. 6.6.1 Huanuotai Biological Company Information
  33. 6.6.2 Huanuotai Biological Business Overview
  34. 6.6.3 Huanuotai Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huanuotai Biological Human Vaccine Adjuvants Product Portfolio
  36. 6.6.5 Huanuotai Biological Recent Developments
  37. 6.7 SEPPIC
  38. 6.7.1 SEPPIC Company Information
  39. 6.7.2 SEPPIC Business Overview
  40. 6.7.3 SEPPIC Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SEPPIC Human Vaccine Adjuvants Product Portfolio
  42. 6.7.5 SEPPIC Recent Developments
  43. 6.8 CSL Limited
  44. 6.8.1 CSL Limited Company Information
  45. 6.8.2 CSL Limited Business Overview
  46. 6.8.3 CSL Limited Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSL Limited Human Vaccine Adjuvants Product Portfolio
  48. 6.8.5 CSL Limited Recent Developments
  49. 6.9 Croda
  50. 6.9.1 Croda Company Information
  51. 6.9.2 Croda Business Overview
  52. 6.9.3 Croda Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Croda Human Vaccine Adjuvants Product Portfolio
  54. 6.9.5 Croda Recent Developments
7 North America by Country
  1. 7.1 North America Human Vaccine Adjuvants Sales by Country
  2. 7.1.1 North America Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Vaccine Adjuvants Sales by Country (2021-2026)
  4. 7.1.3 North America Human Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Vaccine Adjuvants Market Size by Country
  6. 7.2.1 North America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Vaccine Adjuvants Sales by Country
  2. 8.1.1 Europe Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Vaccine Adjuvants Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Vaccine Adjuvants Market Size by Country
  6. 8.2.1 Europe Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Vaccine Adjuvants Sales by Country
  2. 9.1.1 Asia-Pacific Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Vaccine Adjuvants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Vaccine Adjuvants Market Size by Country
  6. 9.2.1 Asia-Pacific Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Vaccine Adjuvants Sales by Country
  2. 10.1.1 South America Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Vaccine Adjuvants Sales by Country (2021-2026)
  4. 10.1.3 South America Human Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Vaccine Adjuvants Market Size by Country
  6. 10.2.1 South America Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Vaccine Adjuvants Sales by Country
  2. 11.1.1 Middle East and Africa Human Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Vaccine Adjuvants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Vaccine Adjuvants Market Size by Country
  6. 11.2.1 Middle East and Africa Human Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Vaccine Adjuvants Value Chain Analysis
  2. 12.1.1 Human Vaccine Adjuvants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Vaccine Adjuvants Production Mode & Process
  7. 12.2 Human Vaccine Adjuvants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Vaccine Adjuvants Distributors
  10. 12.2.3 Human Vaccine Adjuvants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst